Author Profile

Heather Mefford, MD, PhD

Faculty, Department of Cell & Molecular Biology

Heather Mefford, MD, PhD

Heather Mefford, MD, PhD, is a faculty member in the Department of Cell & Molecular Biology at St. Jude.

Stories by Heather Mefford

Boosting whooping cough vaccinations
Boosting whooping cough vaccinations
Clinical

How can hospitals shield vulnerable patients from the whooping cough resurgence?

Elisabeth Adderson, MD

How can hospitals protect patients and staff from resurgent pertussis outbreaks? Learn how we boosted the vaccination rate by 55%.

Why I take part in the cancer survivorship study, St. Jude LIFE
Why I take part in the cancer survivorship study, St. Jude LIFE
Clinical

Why cancer survivors should take part in long-term follow-up studies

Dwight Tosh

The 17th patient admitted to St. Jude in 1962 was successful treated for Hodgkin lymphoma. Find out why Dwight Tosh returns to St. Jude take part in a research study for cancer survivors.

Healing suffering through compassion, presented at TEDx Memphis
Healing suffering through compassion, presented at TEDx Memphis
Clinical

Healing suffering through compassion

Justin N. Baker, MD

Dr. Justin N. Baker shares lessons on compassion from his experience at St. Jude. Watch his TEDx Memphis talk to learn how to help others through difficult times, and know why it matters.

Biostatistical model resolves questions on antibiotic side effects
Biostatistical model resolves questions on antibiotic side effects
Research

Safety in numbers: Advanced biostatistical model resolves questions on vancomycin side effects

Josh Wolf, PhD, MBBS

Dr. Josh Wolf explains how biostatistics resolved safety questions on preemptive vancomycin for acute myeloid leukemia patients after chemotherapy.

A vaccine to prevent cancer? It’s already here.
A vaccine to prevent cancer? It’s already here.
Research

A vaccine to prevent cancer? It’s already here.

Ellis J. Neufeld, MD, PhD

Many adolescents fail to get a key vaccination that can prevent cancer. Learn what doctors know about the HPV cancer vaccine.

The differences in myelodsyplastic syndromes between kids and adults
The differences in myelodsyplastic syndromes between kids and adults
Clinical

Kids aren’t little adults when it comes to pediatric MDS

Jeffery M. Klco, MD, PhD

Myelodysplastic syndromes can lead to leukemia in children. Considered an adult disease, researchers have found molecular differences that may offer new treatments for children with pediatric MDS.

Breastfeeding: Good for Mother, Good for Baby
Breastfeeding: Good for Mother, Good for Baby
Clinical

Childhood cancer survivors and breast-feeding: Good for baby, good for mom

Ginger Carney

Learn how breastfeeding helps childhood cancer survivors reduce late effects, the health problems that occur months or years after treatment.

Five ways to take confirmation bias out of your experimental results
Five ways to take confirmation bias out of your experimental results
Research

Five ways to take confirmation bias out of your experimental results

Charles Rock, PhD

The most important part of research is that you must not fool yourself — and you’re the easiest person to fool.

Heme synthesis linked with acute myeloid leukemia
Heme synthesis linked with acute myeloid leukemia
Research

Blood's oxygen transporter revealed as power source for aggressive pediatric cancer

John Schuetz, PhD

Read how the oncogene MYCN hijacks an oxygen-carrying component of hemoglobin to feed and grow aggressive AML in children.

ASH 2017: Preliminary results show gene therapy gains in X-linked SCID
ASH 2017: Preliminary results show gene therapy gains in X-linked SCID
Research

ASH 2017: Preliminary results show gene therapy gains in SCID

Ewelina Mamcarz, MD

Gene therapy for X-linked SCID resulted in the development of T cell, B cell and natural killer cells without side effects. Read more about the research.